Domestic shipping shortens transit time, reduces the risk of customs hold, and keeps lyophilized BPC-157 within recommended temperature ranges through to laboratory receipt
The risk is not only potency loss
It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment
Pape J, Paraskevopoulos E, Bruchmann M, Wollbrink A, Rudack C, Pantev C
BPC-157 and TB-500: Research Overview BPC-157 and TB-500 are two of the most extensively studied tissue-repair research peptides
What Patients Actually Report Anecdotally (and I want to underscore that word), compounding pharmacy practice sees: Reduced gut symptoms within 3 to 6 weeks for a meaningful subset of patients Improved tolerance to previously reactive foods in some cases, though this is highly variable and unpredictable Stable symptom maintenance in patients with already-controlled IBD Generally good tolerability with few reported adverse effects These are observational reports, not controlled-trial outcomes